Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC30H26Cl2FN3O3 |
InChIKeyCCPUFNJKOGKOOG-AFKAWQRRSA-N |
CAS Registry1818291-27-8 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Preclinical | Austria | 08 Jan 2019 |





